Juarez I, Perez-Flores I, Aiffil Meneses A, Lopez-Gomez A, Calvo Romero N, Rodriguez-Cubillo B
Vaccines (Basel). 2025; 13(2).
PMID: 40006670
PMC: 11860609.
DOI: 10.3390/vaccines13020123.
Wessel R, Dolatshahi S
Nat Immunol. 2024; 25(11):2024-2036.
PMID: 39379658
DOI: 10.1038/s41590-024-01971-1.
Lefranc M, Lefranc G
Immunol Rev. 2024; 328(1):473-506.
PMID: 39367563
PMC: 11659927.
DOI: 10.1111/imr.13399.
Hale G
Immunol Rev. 2024; 328(1):422-437.
PMID: 39158044
PMC: 11659930.
DOI: 10.1111/imr.13379.
Jodice C, Malaspina P, Ciminelli B, Martinez-Labarga C, Biancolella M, Novelli G
Genes (Basel). 2024; 15(7).
PMID: 39062635
PMC: 11275349.
DOI: 10.3390/genes15070856.
The elusive nature of the oligoclonal bands in multiple sclerosis.
Kennedy P, George W, Yu X
J Neurol. 2023; 271(1):116-124.
PMID: 37945762
DOI: 10.1007/s00415-023-12081-7.
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations.
Purcell R, Theisen R, Arnold K, Chung A, Selva K
Front Immunol. 2023; 14:1183727.
PMID: 37600816
PMC: 10433199.
DOI: 10.3389/fimmu.2023.1183727.
Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapy.
Nimmerjahn F, Vidarsson G, Cragg M
Nat Immunol. 2023; 24(8):1244-1255.
PMID: 37414906
DOI: 10.1038/s41590-023-01544-8.
Integration of NMR Spectroscopy in an Analytical Workflow to Evaluate the Effects of Oxidative Stress on Abituzumab: Beyond the Fingerprint of mAbs.
Cerofolini L, Ravera E, Fischer C, Trovato A, Sacco F, Palinsky W
Anal Chem. 2023; 95(24):9199-9206.
PMID: 37278511
PMC: 10285717.
DOI: 10.1021/acs.analchem.3c00317.
Evolutive emergence and divergence of an Ig regulatory node: An environmental sensor getting cues from the aryl hydrocarbon receptor?.
DAddabbo P, Frezza D, Sulentic C
Front Immunol. 2023; 14:996119.
PMID: 36817426
PMC: 9936319.
DOI: 10.3389/fimmu.2023.996119.
Constant domain polymorphisms influence monoclonal antibody stability and dynamics.
Warrender A, Pan J, Pudney C, Arcus V, Kelton W
Protein Sci. 2023; 32(3):e4589.
PMID: 36759959
PMC: 9951194.
DOI: 10.1002/pro.4589.
Antibody Sequence and Structure Analyses Using IMGT: 30 Years of Immunoinformatics.
Lefranc M, Lefranc G
Methods Mol Biol. 2022; 2552:3-59.
PMID: 36346584
DOI: 10.1007/978-1-0716-2609-2_1.
IMGT Nomenclature of Engineered IGHG Variants Involved in Antibody Effector Properties and Formats.
Lefranc M, Lefranc G
Antibodies (Basel). 2022; 11(4).
PMID: 36278618
PMC: 9624366.
DOI: 10.3390/antib11040065.
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial.
Casazza J, Cale E, Narpala S, Yamshchikov G, Coates E, Hendel C
Nat Med. 2022; 28(5):1022-1030.
PMID: 35411076
PMC: 9876739.
DOI: 10.1038/s41591-022-01762-x.
IMGT IG and TR Loci, Gene Order, CNV and Haplotypes: New Concepts as a Paradigm for Jawed Vertebrates Genome Assemblies.
Lefranc M, Lefranc G
Biomolecules. 2022; 12(3).
PMID: 35327572
PMC: 8945572.
DOI: 10.3390/biom12030381.
The Immunogenetics of Autoimmune Blistering Diseases.
Kneiber D, Kowalski E, Amber K
Adv Exp Med Biol. 2022; 1367:173-212.
PMID: 35286697
DOI: 10.1007/978-3-030-92616-8_8.
Ozoralizumab, a Humanized Anti-TNFα NANOBODY Compound, Exhibits Efficacy Not Only at the Onset of Arthritis in a Human TNF Transgenic Mouse but Also During Secondary Failure of Administration of an Anti-TNFα IgG.
Ishiwatari-Ogata C, Kyuuma M, Ogata H, Yamakawa M, Iwata K, Ochi M
Front Immunol. 2022; 13:853008.
PMID: 35273620
PMC: 8902368.
DOI: 10.3389/fimmu.2022.853008.
A Quantitative Approach to Unravel the Role of Host Genetics in IgG-FcγR Complex Formation After Vaccination.
Lemke M, Theisen R, Bozich E, McLean M, Lee C, Lopez E
Front Immunol. 2022; 13:820148.
PMID: 35273603
PMC: 8902241.
DOI: 10.3389/fimmu.2022.820148.
Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections.
Hickerson B, Daniels-Wells T, Payes C, Clark L, Candelaria P, Bailey K
Nat Commun. 2022; 13(1):558.
PMID: 35091550
PMC: 8799657.
DOI: 10.1038/s41467-021-27949-3.
A systems approach to elucidate personalized mechanistic complexities of antibody-Fc receptor activation post-vaccination.
Lemke M, McLean M, Lee C, Lopez E, Bozich E, Rerks-Ngarm S
Cell Rep Med. 2021; 2(9):100386.
PMID: 34622227
PMC: 8484512.
DOI: 10.1016/j.xcrm.2021.100386.